OptimizeRx Strengthens Leadership with CEO Steve Silvestro
WALTHAM, Mass. – OptimizeRx Corp. (Nasdaq: OPRX), a prominent player in healthcare technology solutions, has exciting news. The Company has appointed its Chief Executive Officer, Steve Silvestro, to its Board of Directors. This decision takes effect as the company gears up towards future growth strategies.
Steve Silvestro's Journey at OptimizeRx
Since joining OptimizeRx in 2019, Mr. Silvestro has contributed significantly to the Company's objectives. He became CEO in March 2025, having initially served as the interim CEO from January 2025. His extensive experience and understanding of the Company will surely enhance the leadership team's capability to execute growth plans effectively, aligning with customer expectations and boosting shareholder value.
During his tenure, Steve has laid down strategic initiatives aimed at strengthening OptimizeRx’s relationships with customers while establishing a robust framework for sustainable long-term shareholder value. Lynn Vos, Chairperson of the Board of Directors, expressed her admiration for Steve's leadership and the substantial progress achieved since he took the role of CEO.
Vision for the Future
As Steve expressed, it is a privilege to work alongside an experienced Board. He believes that the direction OptimizeRx is heading signifies a strong potential for growth in 2025 and beyond. His commitment includes enhancing customer experiences, solidifying relationships with pharmaceutical partners, and progressing towards a recurring revenue model. This mindset reflects the ambition to evolve in the healthcare landscape and drive innovations that benefit patients.
About Stephen L. Silvestro
Steve's background is impressive. Before stepping into the CEO position, he held the role of Chief Commercial Officer and President at OptimizeRx. His tenure encompasses a wealth of experience in the healthcare technology sector. Previously, Steve showcased his leadership skills at CCH® Tagetik under Wolters Kluwer, enhancing their software solutions for corporate performance management.
Contributions from the Board
The appointment emphasizes the Board's strategy to enhance its diversity in perspectives and experience, which is crucial for innovative decision-making. The Company's focus on operational excellence is underscored by Steve's joining the Board, further solidifying his commitment to strategic leadership. The initiatives undertaken by Steve and his team showcase their vision for sustained growth and the companies' future direction.
About OptimizeRx
OptimizeRx is redefining connections between life science brands, patients, and healthcare providers. The Company’s platform leverages cutting-edge AI-driven tools, like Dynamic Audience Activation and Micro-Neighborhood Targeting, to enable precise and timely engagement between all parties involved in healthcare delivery.
With a clear focus on patient-centric technology solutions, OptimizeRx is dedicated to ensuring safe and meaningful interactions that lead to enhanced patient outcomes. Headquartered in Waltham, Massachusetts, the Company collaborates with top pharmaceutical and life sciences firms to innovate and improve healthcare connectivity.
Frequently Asked Questions
What recent appointment was made at OptimizeRx?
OptimizeRx appointed CEO Steve Silvestro to its Board of Directors to bolster leadership and strategic direction.
What is Steve Silvestro's role before becoming CEO?
Steve Silvestro previously served as Chief Commercial Officer and President before becoming the CEO in March 2025.
What strategic initiatives is OptimizeRx focusing on?
OptimizeRx is focused on enhancing customer experiences, deepening partnerships with pharmaceutical firms, and transitioning towards a recurring revenue model.
How does OptimizeRx connect with healthcare providers?
Through their innovative platform, OptimizeRx integrates advanced tools to facilitate timely engagement with healthcare providers and patients.
Where is OptimizeRx located?
OptimizeRx is headquartered in Waltham, Massachusetts, and collaborates with leading life sciences companies in the industry.
